Venetoclax plus acalabrutinib becomes the first fully oral, fixed-duration option for treatment-naïve CLL, adding a differentiated targeted approach to frontline regimen selection. A defined treatment ...
Cardiovascular comorbidities were equally prevalent in full-dose and reduced-dose groups, suggesting well-controlled cardiovascular disease need not contraindicate standard dosing. Early dose ...
It may be possible to detect Richter transformation (RT) years before it actually occurs in patients with chronic or small lymphocytic leukemia, research indicates. New research is helping to change ...
Our Mug Shot of the Week winner is Patsy Ramsey. Patsy wins a Best of the Bluegrass mug for her photo she took in Climax, Kentucky, of her son's barn cat named Agnes. If you have a photo that captures ...
Virginia native and noted country music artist Patsy Cline died in a plane crash in Tennessee. Cline is buried at Shenandoah Memorial Park in Winchester. Gray Media, parent company of WDBJ7, is ...
Actor Paula Prentiss (1975’s “The Stepford Wives”) is 88. Movie director Adrian Lyne (“Fatal Attraction”) is 85. Singer Chris Rea is 75. Actor-singer Ronn Moss (“The Bold and the Beautiful”) is 74.
To overcome the challenges of current CAR T-cell strategies and enhance their efficacy and specificity for acute myeloid leukemia, researchers at the Sino-American Cancer Foundation and collaborating ...
What Is It, and Why Does It Matter? The FDA has approved a new combination treatment for adults with certain cancers of the blood and lymphatic system. The targeted regimen combines Calquence ...
AbbVie (ABBV) said Friday that the U.S. FDA has approved a supplemental new drug application for its combination regimen of Venclexta (venetoclax) and acalabrutinib to treat previously untreated ...
The FDA approved acalabrutinib (Calquence) plus venetoclax (Venclexta) for previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma as the first all-oral, fixed-duration ...
In "Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how clinicians can communicate effectively and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results